Drug Trial Radar · NCT01192789
Community Case Management of the Severe Pneumonia With Oral Amoxicillin in Children 2-59 Months of Age
Last checked: Nov 19, 2026Latest source record: May 22, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
4,070
Actual
Start
Feb 2008
Primary completion
Mar 2010
Study completion May 2010
Sponsor
- Lead sponsor
- Aga Khan UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- World Health Organization; Boston University
- First posted
- Sep 1, 2010
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 2 months, up to 59 months
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Two-arm cluster randomized controlled trial located in Hala district, Pakistan to determine the impact of using Lady Health Workers (LHW) of National Program for Family Planning and Primary Health Care to diagnose and manage severe pneumonia with oral amoxicillin on treatment failure rates at day 6 among 2-59 month old children. LHWs in the control arm receive a refresher in standard pneumonia case management. LHWs in the intervention arm receive standard training that is enhanced to include training in the recognition of severe pneumonia and its home management with oral amoxicillin. Clusters are by Union Council (UC), administrator units consisting of 7 to 25 LHWs; each UC is randomized to either enhanced pneumonia case management with oral amoxicillin therapy (intervention) for severe pneumonia or standard case management and referral to the nearest health facility for treatment (control). Process indicators reflecting the LHW's ability to assess, classify and treat pneumonia in the intervention group and cost-effectiveness data is also being collected. Primary Hypothesis: Enhanced pneumonia case management and oral amoxicillin therapy for severe pneumonia delivered by LHWs in the community will result in a reduction in treatment failure among children 2 - 59 months of age with severe pneumonia who are treated by the LHW compared with those referred for care by the LHW. Secondary Hypotheses: 1. The proportion of treatment failure, \[persistence of lower chest indrawing (LCI) or need for second line treatment between day 3 and day 14\], will be less in the intervention arm compared with the control arm. 2. LHWs can adequately assess, classify, and treat severe pneumonia in 2 - 59 month old children, and adequately recognize and refer children who present with danger signs during initial antimicrobial therapy.
Conditions
- Severe Pneumonia
Interventions
AmoxicillinDrug
LHWs treat severe pneumonia with oral amoxicillin at 90 mg/kg/day.
Referral to Health facilityOther
LHWs refer the severe pneumonia case to local health facility or private practitioner. In case of refused referral , treat the case with oral cotrimoxazole for 7 days.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The development of clinical treatment failure at day 6 among those children initially evaluated for ARI needing assessment (ANA) by a LHW at the domiciliary level.Time frame: At day 6
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Aga Khan University Research Office, Matiari
Matiari, Sidh, Pakistan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.